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The attack mechanism of complement (1)  has been defined as those complement 
proteins the binding  of which to the target membrane is necessary for the production of 
membrane damage. It is distinguished from  the recognition and activation mecha- 
nisms of complement which, although capable of attaching to the target cell, may act 
from the fluid phase or from the surface of another cell. Earlier work (2) demonstrated 
that the attack mechanism is comprised of five different components, namely C5,1 C6, 
C7, C8, and C9. The present study was designed to obtain information which pertains 
to the molecular arrangement of these five proteins on a membrane under attack by 
complement. The accumulated evidence strongly suggests  that the membrane-bound 
attack mechanism consists of a compact decamolecular assemblage with a  total mo- 
lecular weight of approximately 1 million. 
Previous investigations have shown a requirement of protein binding to  the target 
cell for expression of hemolytic activity for  C5  (3-5), C6  (6,  7),  2 C8(8),  and  C9  (9). 
They have also pointed out a functional interdependence  between C5, C6, and C7  (3), 
particularly  in the formation of ECS, 6, 73 (2, 6). In addition, these three proteins were 
found to have an affinity for each other in free solution, enabling them to enter into re- 
versible protein-protein interactions (3).2 Such interaction has  recently been demon- 
strated to occur also between C8 and C9. 4 Thus information published to date raised 
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the possibility of the formation of a macromolecular assembly of C5-9 on  the surface 
of a  target cell.  Simultaneous experimentation with all  five proteins was necessary, 
however, to deduce the molecular concept advanced below. 
Materials and Methods 
Human Complement Components and  Complement Reagents.  Partially  purified  macro- 
molecular C1 was prepared from human serum according to Nelson et al.  (10). C2 was puri- 
fied as described previously (11) and was used exclusively in its oxidized form (12). C3  (13), 
C4 (14), C5 (13), and C6 (15) were obtained according to published methods. C7 was isolated 
in highly purified form according to a method which will  be described in detail elsewhere.  5 
Highly purified C8 and C9 were prepared from the same pool of human serum by modifica- 
tions of the previously published methods (8,  9).  These modifications will be presented in 
detail elsewhere.  6 The C8 and C9  thus prepared were judged free of demonstrable contam- 
ination by chromatographic, electrophmetic, and immunochemical criteria. Protein concen- 
trations of the purified components were determined by the Lowry method  (16) using the 
following standards: C3 for C3, C6, and C7; C4 for C4; C5 for C5; and human Cohn fraction 
II for C8 and C9. 
Complement components used  for  quantitative uptake  experiments were trace  labeled 
with either 125I or  131I by the chloramine-T method  (17).  After labeling, each component 
was dialyzed for 48 hr against 4 X  10 liters of 0.15 M NaC1 containing 50 mM chlorampheni- 
col  (donated by Parke,  Davis  & Company, Detroit, Mich.)  and  25  #M kanamycin sulfate 
(Bristol Laboratories, Syracuse, N.Y.).  The dialyzed preparations were centrifuged for 40 
rain at 45,000 g to remove aggregates. The hemolytic activities of C5 and C9 were essentially 
unchanged by labeling, while C6 and C8 lost maximally 30  40%. The specific radioactivities 
of the preparations used for experiments reported in this communication were: C5, 4.5-22  X 
105 cpm/pg; C6 6.5-8 X  104 cpm/#g; C8,  1.44-3.94  X  106 cpm/#g; C9,  1.65  4 X  106 cpm/ 
#g. Bovine serum albumin (Pentex Biochemical,  Kankakee, Ill.) was added  as  carrier to  a 
final concentration of 1 mg/ml and the preparations were stored at 0°C. 
A  reagent containing C3,  C6,  and  C7  was prepared by  carboxymethyl (CM)-cellulose 
column  chromatography by  a  minor modification of  the published method  (8):  only  the 
fractions corresponding to the peak of the breakthrough protein were pooled and the pH was 
adjusted to 7.0 with 1 M NaOH before freezing. 
Preparation of Sheep P'rythrocyle--Antibody-Complement Complexes.  EAC1,4,°xy2  was 
usually prepared from iodinated human  serum  (18) and  phloridzin:  175  mg  of phloridzin 
(K  & K  Laboratories Inc., Plainview, N.Y.)  was dissolved in  15  ml  of isotonic Veronal- 
buffered saline (GVB)  by briefly heating to 70°C. After rapid cooling to approximately 40°C, 
the phloridzin solution was mixed with an equal volume of sensitized sheep erythrocytes (5 X 
108 cells/ml) prewarmed to 37°C. After 1 rain,  2 ml of the iodinated serum was added and 
the mixture was incubated at 37°C for 14 mix with periodic agitation. The reaction mixture 
was then added to 90 ml of ice-cold  GVB,  centrifuged, washed twice in 50-rot poltious, and 
resuspended in GVB to a final cell concentration of 5 X  l0 s cells/ml. These cells were usually 
employed for the preparation of EAC1-7  as follows.  To  15  ml of EAC1,4,°xy2  (5  X  10 a 
cells/ml) was added a mixture of 1 ml of the C3, C6, C7 reagent, 200/zl of 40% glucose,  and 
200 #g of C5. This mixture was incubated 45 min at 37°C,  centrifuged, washed three  times 
with 50 ml cf cold GVB,  and resuspended in GVB to the appropriate cell concentration. For 
the experiments involving determination of the molar C5/C6 ratio on EAC1  7, the EAC1,4, 
°xy2,3 cells were prepared from EA and purified  components (22!. 
EAC1-8 was prepared by incubation of EACI-7  (6  X  10  7 cells/ml) with an appropriate 
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amount of C8 for 30 min at 37°C.  The cells were then centrifuged and washed three times 
with portions of GVB equal to one-half the original volume. 
Antisera.--Monospecific antisera to C3, C5,  C6, C7, and C8 were produced in rabbits by 
injection into the popliteal lymph nodes according to Goudie et al. (19). For C3, C6, C7, and 
C8,  the protein band was sliced from polyacrylamide disc electrophoresis gels. The gel slices 
were crushed and mixed with an equal volume of Freund's complete adjuvant and 100/zl  of 
the mixture containing 20/zg protein was injected into each lymph node. 1 month later 50 
#g of protein in 200 #1 of a similar mixture was injected intramuscularly into each of two sites 
in the hindquarters. The rabbits were bled 6-8 days later. The same procedure was followed 
for C5, except the protein was not sliced from polyacrylamide gels but injected with an equal 
volume of Freund's complete adjuvant only. 
Purified "y-globulin fractions of each antiserum and normal rabbit serum, free of rabbit 
C8 and C9, were prepared as follows. 20 ml of each serum was dialyzed 24 hr against 10 liters 
of cold sodium-phosphate buffer, pH 7.0,  conductivity 1.5 mmho/cm. After removal of in- 
soluble protein by centrifugation at 3000 g for 30 min, the dialyzed sample was applied to a 
3  )<  60 cm triethylaminoethyl (TEAE) column equilibrated with the dialysis buffer and the 
breakthrough protein was collected and concentrated by precipitation at 0°C with ammonium 
sulfate at 50~  saturation. The precipitate was washed three times with 50 ml of 50% satu- 
rated ammonium sulfate, dissolved in and dialyzed against 0.15 M NaC1  (2  X  10 liters for 2 
days at4°C), heated at 56°C  for 2 hr,  cleared of aggregates by centrifugation (as  above), 
and stored at -70°C. 
C8 and  C9 Hemolytic  Assays. The samples to be assayed for C8 activity were incubated 
with 3 X  107 EAC1-7 and an excess (100 CHs0) of C9 at 37°C in a final volume of 500pl of 
GVB. The reaction was terminated (usually after 30 min) by transferring the tubes to an ice 
bath, addition of 1 ml of ice-cold 0.15 ~  NaC1, and immediate eentrifugation. Oxyhemoglobin 
in the supernatants was quantitated by reading the absorbance at 412 nm. The results were 
corrected for controls in which GVB was substituted for the sample. C9 hemolytic activity 
was quantitated by the same method, except 100 CHs0 of C8 replaced the C9. 
Determination  of the Molar Ratio  of Cell-Bound C5 and C6 on EAC1-7.--Various amounts 
of C6-131I (200 ng-10 #g)  and a constant amount of C5-12sI  (10 #g) were incubated for 20 
min at 37°C with 2.5  X  107 EAC1-3 cells in the presence of C7  (10/zg). The total reaction 
volume was 300 #I. After incubation the tubes were centrifuged and  the cells washed four 
times with 5-ml portions of GVB at room temperature. The final cell buttons were resuspended 
in 500/21  of GVB,  transferred to another set of tubes, and analyzed for radioactivity in a 
well-type scintillation counter. The cells were then hemolyzed by the addition of 2.5 ml of 
water, the absorbance of the lysate was read at 541  nm, and the data were normalized to 
counts per minute per 2.5  )<  107 ceils. Specific C6-131I and C5-125I uptakes were calculated 
by subtracting the nonspeciflc uptake of these components by EAC1,4. The molar ratios of 
the specifically  bound C5-125I to C6-131I were calculated by assuming a molecular weight of 
180,000 for C5 and 125,000 for C6. 
Determination  of Molar Ratio  of Bound C8 and Bound C5 on EAC1-8.--Three populations 
of radiolabeled EAC1-7  cells were made by reacting 1.75 >(  109 EAC1,4, °xy2 cells with 2.5 
/zg of C5-125I and respectively with 250, 500, and 750 #1 of the C3, C6, C7 reagent in a final 
volume of 5.0  ml.  The  amount of C5-125I uptake was observed to  remain constant with 
amounts of C3, C6, C7 reagent greater than 400 #1, thus indicating an excess of C6 and C7. 
The radiolabeled EAC1-7  cells were washed four times in 10 ml of 4°C  GVB and 1.5  >(  108 
cells were placed in each of nine tubes. One tube served as a control from which the number 
of C5-]2sI molecules bound per cell was calculated. The other tubes in each series received 
C8-125I ranging from 150 to 3500 C8 molecules offered/cell. The reaction volume was 900 lzl 
and the incubation was for 45 rain at 37°C with continuous shaking. The cells were diluted 
and washed four times in  10  ml of GVB  at room temperature and  the tubes were briefly 
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in 500 #1 of GVB, counted as described above, and the counts were normalized to 1.5  )<  l0  s 
cells. Nonspecific uptakes of C5-125I  and C8-12sI were obtained in all experiments by treat- 
ing a  similar number of EAC1,4, °xY2 with the appropriate amounts of the labeled compo- 
nent in  parallel with  the experimental incubations. The  specific C8-125I  uptake was calcu- 
lated  by subtracting  the  total  C5-12aI  uptake  and  the nonspecific C8-125I  uptake from  the 
total counts. For calculation of the molar ratio of the specifically bound C5-125I  to C8-125I, 
the molecular weight of C8 was assumed to be 153,000  and that of C5, 180,000.  Alternatively, 
differential labeling was used, i.e., C5-125I  and C8-1aII. 
Determination  of Molar  Ratio  of Bound  C9  to  Bound  Cg  on EAC1-9.---6  ml  of EAC1-7 
(5)<  10  s  cells/ml) was incubated with  1 #g of C8-125I  for 60  min at 37°C. The cells were 
washed four times with 10 ml of GVB at room temperature and 1 )<  10  s cells were placed in 
each of nine tubes. One tube served for determining the number of C8 molecules bound per 
cell and the others received C9-125I  ranging from 200 to  19,600  molecules offered/cell. Incu- 
bations were in a  total volume of 900/zl for 45  min at 37°C with continuous shaking.  The 
reaction mixture was diluted to 5  ml with GVB  and  the cells and stroma were collected on 
Millipore filters (Millipore Corp., Bedford, Mass.)  as described below. Nonspecific uptake of 
C8-12aI  was determined  by using EAC1,4,°xy2  and  of C9-t25I  by using EAC1-7  (always 
from the same stock cell suspension which had been used to prepare the radiolabeled EAC 1-8). 
The Millipore filters used in these experiments were 25  mm in diameter, pore size 0.45 # 
(Millipore No. HAWP025), and were soaked for at least 12 hr in 1% bovine serum albumin 
(BSA)  to minimize nonspecific uptake of  125I-labeled proteins. To  collect a  sample  a  filter 
was placed in a collecting apparatus  (similar to Millipore No. XX10 025 00) and the vacuum 
was applied. The  vacuum  employed was provided by a  water aspirator  and was manually 
regulated  by use of a  "bleeding" valve in  the vacuum line,  thereby insuring a  smooth and 
gentle washing action.  The cell or cell-stroma suspension to  be collected was placed in  the 
collecting apparatus and allowed to drain to a volume of about 0.5 ml, at which time 5 ml  of 
distilled water were added. This converted any unlysed cells to stromata  After the water had 
drained to approximately 1 ml, 4 ml of 0.15 M NaCI was added and the apparatus was drained 
to dryness. Next the stroma were washed with 2-5 ml portions of 0.15 M NaC1 and the filters 
were placed in 12  X  75 mm tubes and counted in a well-type scintillation counter. 
This procedure was validated by preliminary experiments which indicated that the filtra- 
tion  and  washing resulted in  minimal loss of C8-125I  from  EAC1-8  and  EAC1-9 within  a 
wide range of C8 and C9 multiplicities. Thus, the filters were able to quantitatively retain  the 
fragments of complement-lysed cell membranes, even when  100%  lysis of EAC1-9  had  oc- 
curred, and, in addition, the bound C8  (and presumably the C9) was not washed from these 
fragments. 
The specific C9-125I  uptake was calculated  by subtracting the total C8-125I  uptake and 
the  nonspecific C9-12aI  uptake  from  the  total  counts.  For  calculations of  the  C9-125I-to  - 
C8-12~I  molar ratio on the cell surface, the molecular weight of C9 was assumed to be 79,000. 
In some experiments a differential labeling technique was used: C8-125I  and  C9-1~II. 
Inhibition of C8 Uptake and Hemolysis of EAC1-7 and C9 Uptake and Hemolysis of EACI-8 
by Various Antisera.~  )<  l0  s EAC1-7 or EAC1-8 cells in 500 #1 of GVB were added to 2.0 
ml of GVB containing increasing amounts of T-globulin fraction from either antiserum (anti- 
C3,  -C5,  -C6, -C7, -C8, or -Forssman) or normal rabbit serum. After incubation for 15 min 
at 37°C, 5 ml of 4°C GVB was added, the tubes were centrifuged, and the cells were washed 
three times with 5-ml portions of the same buffer. The washed cell pellets were resuspended 
to a  concentration of 5  )<  l0  s cells/ml. The residual hemolytic potential of the cell-bound 
complement components was found  by incubation  of the  antibody-treated  EAC1-7  with 2 
CHs0 units of C8 and excess C9 and the antibody-treated EAC1-8 with 2 CHs0 units of C9. 
The  hemolytic reactions were  stopped  at  40-50%  hemolysis in  the control incubations,  a 
value well within the linear range of the reaction. To  ascertain the effect of antibody treat- 
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40 min at 37°C with C8-12~I or C9-125I, respectively. The selected dose of radiolabeled C8  or 
C9 was determined from preliminary experiments to be favorably situated on the linear por- 
tion of the uptake curve for cells which had not been exposed to rabbit "y-globulin (GVB cells). 
The uptakes of the C8-12~I and C9-12~I were quantitated by the same methods described in 
the sections on molar ratios of cell-bound C5 to C8 and C8 to C9, respectively. The results 
are expressed as per cent of normal rabbit ~-globulin controls which showed essentially con- 
stant hemolysis and uptake of radiolabeled C8  and C9  over the protein range studied and 
differed by no more than a few per cent from GVB cells. 
Effect of Various Antisera  on Persistence of Cell-Bound C5 and Co°.--EAC1-7  were made 
with C5-1~5I as described in the section on the molar ratio determination of C5  to C8,  and 
EAC1-8 were made with C8-125I as described in the section on the molar ratio determination 
of C8 to C9. The cells were washed four times with 10 ml of GVB at room temperature and 
1.5 X  108 of the EAC1-7 or EAC1-8 cells were placed in a series of tubes and incubated with 
GVB  or 250 #g  (50 #g/3  )<  107 cells) of the "),-globulin fraction from normal rabbit serum, 
anti-C3, -C5, -C6, -C7, or -C8 in a total volume of 750 #1 for 30 rain at 37°C. The cells were 
washed three times with GVB  at room temperature and the bound C5-125I or C8-125I was 
quantitated by the usual methods described in other sections. 
Microtiter Procedures.--Microfiter  plates and microtiter dilutors (Cooke  Engineering Co., 
Alexandria, Va.)  were used for the  titration of  the various antibodies employed in  these 
studies. 25 #1 of GVB were placed in each well and 25 #1 of the ~-globulin fraction to be tested 
were delivered to the first well of the series After doubling dilutions were made by employing 
25-#1 microtiter dilutors, each well  received 25/zl of the appropriate cell suspension which 
was at a concentration of 108 cells/ml. After the plates were agitated and stored at 37°C for 
30  min they were agitated again and stored at 4°C  overnight and  the settling pattern was 
recorded. 
Analysis of C9 Hemolytic Dose Response and Binding  Reactions.--A tube containing 5 ml 
of EAC1-7  (5  X  l0  s cells/ml) was incubated with 0.1/zg of C8-125I (4.5 X  l0  b cpm//zg) for 
20 min at 37°C. The radiolabeled cells were washed four times in 10 ml of GVB at room tem- 
perature and 5 X  107 cells were placed in a series of eight tubes. The first tube in each series 
was used to determine the number of C8-125I molecules bound per cell. The other tubes re- 
ceived amounts of C9-12~I (1.65 X  106 cpm/#g) ranging from 25  to 1680 molecules offered 
per cell. The cells were incubated in a total volume of 500 #1 for 60 rain at 37°C with continu- 
ous shaking. The reaction mixtures were then diluted to 2.5 ml with 0°C GVB, centrifuged, 
and the extent of lysis was quantitated by determination of the absorbance of the superna- 
tants at 412 nm. The cell pellets and supernatants containing cell stroma were quantitatively 
collected on Millipore filters and counted as described above. The  specific  C9-125I  uptake 
was also calculated as described above. 
RESULTS 
Molecular Ratios of Attack System Components on the Target Cell Surface.--A 
prerequisite for the formulation of a  molecular model of the attack system was 
the determination of the stoichiometry of these cell-bound complement mole- 
cules. Measurement of the C5/C6 ratio was approached in three different ways. 
One  series of  experiments was conducted by  offering EAC1,4,°xY2,3,  a  con- 
stant amount of C5-125I,  various amounts of C6-13q, and an excess of unlabeled 
C7. The cells were washed and the quantities of bound C5  and C6 were meas- 
ured (Fig. 1). The supernatants from these reaction mixtures, upon incubation 
with  E,  yielded EC5,6,72  and  the molar  ratio  of  bound  C5  and  C6  was  de- 
termined.  In  another  series  of  experiments,  2  a  hemolytically  active  radio- 554  MEMBRANE ATTACK MECHANISM OF  COMPLEMENT 
labeled  C5,6 complex was generated in solution by reacting C5-125I and C6-131I 
in the presence of trypsin3 After addition of soybean trypsin inhibitor,  E  were 
treated  with  the reaction mixtures plus C7. The cells were washed and bound 
C5 and C6 were determined. The data obtained in all three types of experiments 
led to the conclusion that the molar ratio of cell-bound C5 and C6 was approxi- 
mately 1.0 and that it was independent of the absolute and relative amounts of 
C5 and C6 input and uptake. 
In order to determine the molar ratio between cell-bound C5 and C8, EAC1-7 
was prepared which had known numbers of C5-12~I  molecules per cell. In a typical 
experiment  EAC1-7  with  157,  185,  and  191  C5  molecules  (and  presumably 
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FIG. 1.  Demonstration of proportionality  between C5 and C6 uptake by EAC1,4, °xy2,3 
and of an equimolar ratio  of cell-bound C5 and  C6.  10/zg of C5-12~I and 200 ng-10/zg of 
C6-Z3tI were incubated with  10 #g of C7 and 2.5 X  107 EAC1,4, °xY2,3 cells for 20 min at 
37°C in a total volume of 0.3 ml. The cells were washed and the number of specifically bound 
C5 and C6 molecules per cell was determined. The C5/C6 ratio  on the cell surface was con- 
stant over a wide range of C6 input. 
C5,6,7  sites)  per cell were  incubated  with  increasing  amounts  of C8-125I and 
the specific  C8 uptake was determined.  The results  (Fig.  2)  indicate  that the 
C8/C5 ratio on the target cell surface increased with C8 input and approached 
1.0 asymptotically. 
The molar ratio of cell-bound C8 to C9 was obtained by using EAC1-8, made 
with  CS-t2aI, and radiolabeled  C9. Fig. 3 depicts the results of a  typical experi- 
ment inwhich EAC1-8 possessing I09 C8 molecules per cell was reactedwith in- 
creasing  amounts  of  C9-125I. The molar C9/C8  ratio  increased  with  C9 input 
and at saturation of C9 binding sites approached 6. 
Studies of the Spatial Arrangement  of C5-C9 on the Target Cell Surface  Using 
Specific  Antibodies  to Complement Proteins.--The  availability  of specific anti- 
sera to various human complement proteins provided a means for the exploration 
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EAC1-7 cells were treated with the 3,-globulin fraction of a monospecific rabbit 
antiserum to either C3, C5, C6, C7, or Forssman antigen. These cells were then 
tested for their ability to bind radiolabeled C8 and to undergo lysis in the pres- 
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FIG. 2.  Demonstration of equimolarity between bound C8 and bound C5  at saturation 
of C8 binding sites on EAC1-7. Relationship between specific uptake of C8 and C8 input for 
three cell preparations which differed in the number of specifically  bound C5 molecules per 
cell. The reaction mixtures contained 1.5  X  108 EAC1-7  cells and the indicated amount of 
C8-z25I in a volume of 0.9 ml and were incubated for 45 min at 37°C. 
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FIG. 3.  Binding  of multiple  C9  molecules per  C8  molecule on  EAC1-8.  Relationship 
between specific uptake of C9-125I and C9 input using EACI-o with 109 C8 molecules per 
cell. The reaction mixtures contained 1.0 >(  10  s cells and the indicated amount of C9-1~5I in 
a volume of 0.9 ml and they were incubated for 45 rain at 37°C before the lysed and unlysed 
cells were collected and washed on Millipore filters. 
Fig. 4, antibody to C5, C6, or C7 inhibited C8 uptake, whereas anti-Forssman 
and anti-C3 had no significant effect. As shown in the bottom half of Fig. 4, 
antibody to C5 or C6 also inhibited lysis of EAC1-7 while anti-Forssman was in- 
effective. Although higher levels of anti-C3 were apparently slightly inhibitory, 
this cannot be assigned significance because of intense agglutination of the cells 
(see below). In contrast to the above antisera, anti-C7 gave somewhat incon- 556  ME3cIBP~4.NE ATTACK MECHANISM OF  COMPLEMENT 
sistent results; while it inhibited C8 uptake in every experiment, inhibition of 
hemolysis was not always demonstrable and was at best marginal. 
In a second series of experiments EAC1-8 cells were treated with the 7-globu- 
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FIG. 4.  Inhibition by various complement antisera  of the interaction  between FAC1-7 
and C8. EAC1-7 were pretreated with increasing amounts of the "y-globulin  fraction from vari- 
ous antisera, or normal rabbit serum, and assayed for their ability to bind radiolabeled C8 
and for their susceptibility to hemolysis by limited amounts of C8 and excess C9. The results 
are expressed as the per cent of the average hemolysis or C8 binding obtained with normal 
rabbit "g-globulin  treated cells, which were assigned a value of 100%. The control cells them- 
selves gave 65% hemolysis and C8-t25I binding of 3480 cpm/1.5  X  108 ceils. 
were assessed for their ability to bind C9 and to undergo hemolysis by C9. The 
results of a representative binding experiment are illustrated in the upper half 
of  Fig. 5.  They indicate that antibody to  C5,  C6,  C7,  or C8 can inhibit the 
binding of C9 to EAC1-8, anti-C8 always producing the greatest degree of in- 
hibition of the antisera tested. As shown in the lower half of Fig. 5, hemolysis by KOLB~ HAXBY,  ARROYAVE~ AND  MULLER-EBERHARD  557 
C9 was strongly inhibited by anti-C8 and anti-C5. However, it was unaffected 
by anti-C6 or anti-C7,  although both antisera  reduced  C9 binding.  This  ap- 
parent discrepancy will be explained in the Discussion. 
Inhibition of C8 and C9 binding by the various antibodies was most probably 
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Fro. 5.  Inhibition by various antisera of  the interaction of EAC1-8  with C9.  EAC1-8 
were pretreated with the various rabbit ")'-globulin fractions as described in the legend of Fig. 
4, with the addition of anti-C8, and assayed for their ability to bind radiolabeled C9 and for 
their ability to undergo hemolysis by limiting C9. The results are expressed as in Fig. 4. The 
control cells gave 44% hemolysis and C9-Z25I binding of 6044 cpm/1.5  ;<  108 cells. 
due to sterical hindrance imposed by the antibodies. Before this conclusion could 
be drawn it was necessary to show that treatment with antibody caused no dis- 
sociation of complement molecules from the  target  cell  surface.  The data  in 
Table I  indicate that both C5-12~I on EAC1-7 and C8-125I on EAC1-8 remained 
associated with the cells upon treatment with the antibodies. It was also neces- 
sary to test whether the antibody-dependent inhibition was a function of the 558  MEMBRANE  ATTACK MECHANISM  OF  COMPLEMENT 
TABLE  I 
Persistence~'Cell-BoundC5andCgon  Cells Treat~ with 
VariousComplementAntisera 
Residual radioactivity after treatment with: 
Cell type  Normal 
GVB  rabbit  Anti C3  Anti-C5  Anti-C6 
-f-globulin 
Anti-C7  Anti-C8 
EAC1-7  20,400  20,200  21,500  19,700  21,200  19,270  N.D. 
(C5A25I) 
EAC1-8  8930  8500  9000  9100  9280  8840  8900 
(C8-~I) 
Treatment:  50 #g ~-globulin fraction per  3  X  107 cells,  15  min, 37°C.  Radioactivity  is 
expressed as counts per minute per 1.5  X  108 cells. 
TABLE  II 
Agglutination of Complement-Erythrocyte Intermediates by Complement Antisera 
Cell type 
Minimum agglutinating dose (micrograms per 3  X  10~ cells) 
of ~,-globulin fraction of anti: 
Forssman  C3  C5  C6  C7  C8 
EAC1-3  7.1  3.2  ..... 
EAC1-7  7.1  3.2  1.5  0.7  0.2  - 
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FIG.  6.  Demonstration of sigmoidal binding and hemolytic dose response curves for C9. 
EAC1-8 possessing 59 C8 molecules per cell were offered increasing amounts of C9-125I and 
the extent of hemolysis recorded. The stroma and remaining cells were collected on Millipore 
filters and the C9-125I specifically bound per cell was determined. KOLB~ HAXBY~ ARROYAVE, AND M?JLLER-EBERItARD  559 
degree of cellular agglutination. From Table II and Figs. 4 and 5 it is apparent 
that there was no correlation between the minimum agglutination dose and the 
degree of inhibition. Moreover,  anti-C3  which  produced strong  agglutination 
FIG. 7.  Photograph of a  model of the decamolecular  membrane attack mechanism  of 
complement showing three stages of its assembly. The spheres were made of modeling clay, 
the relative weights being proportional to the molecular weights of the complement proteins 
C5-9. The numerals  refer to the corresponding  complement  components.  (a)  Model of the 
membrane-bound  C5,  6,  7  trimolecular complex  displaying triangular geometry, and  con- 
stituting the proposed binding site for C8. (b) Model of the tetramolecular complex C5, 6, 7, 8 
having the geometry of a tetrahedron. (c) Model of the fully assembled decamolecular C5-9 
complex, exhibiting two C9 trimers bound symmetrically in triangular arrangement to the 
C8 portion of the tetrahedron (the C9 trimer on the backside of the complex is only partially 
visible). 
(complete settling of the cells within 5 rain) had little effect upon the hemolytic 
and binding reaction of C8  and  C9.  Anti-C8,  on  the  other hand,  was a  weak 
agglutinator of EAC1-8 but a potent inhibitor of C9 uptake and hemolysis. 
Since the above data suggested that the C8 binding site was on or near C5, C6, 
and C7,  the question arose as to whether binding of C8 to EAC1-7  influenced 560  MEMBRANE  ATTACK MECHANISM  OF  COMPLEMENT 
their agglutination by anti-C5, anti-C6, or anti-C7. The data (Table II)  indi- 
cate that these antibodies agglutinated both EAC1-7 and EAC1-8 to about the 
same degree. Therefore, the C8 binding apparently does not completely obscure 
C5, C6, or C7 from availability to antibody. This is in agreement with the hemo- 
lytic and binding experiments presented in Fig. 4, in which these antisera showed 
maximal inhibition of about 50-60%. 
Comparative Analysis  of C9 Binding  and of C9-Dependent Hemolysis.--The 
multimolar ratio of cell-bound C9 to C8 raised the possibility that C9 uptake is 
a  cooperative process. Therefore, experiments were initiated to establish a  C9 
binding  curve and  to  compare it with  a  C9  hemolytic dose response curve. 
EAC1-8 cells possessing 59  C8 molecules per cell were reacted with increasing 
amounts of C9-125I. As seen in Fig. 6, both curves showed sigmoidal behavior, 
indicating cooperativity in  C9 binding and the requirement of more than one 
molecule of C9 for achievement of a lyric effect. 
DISCUSSION 
From the results presented above and from other available data, the following 
tentative concept may be deduced. After activation of C5, i.e., cleavage of the 
molecule into C5a and C5b by C4,2,3  (1), C5b, C6, and C7 are bound to the 
surface of a membrane in the form of a complex. The simplest and most probable 
geometry of this trimolecular complex is a  triangular arrangement, each com- 
ponent contributing one molecule to the triangle. Since the molecular weight of 
CSb is 165,000 and that of C6 and C7 each approximately 100,000,  the particle 
weight of the complex is about 365,000. The central region of the triangle is 
thought to constitute the binding site for C8. It is fomned by limited portions of 
the surface of each of the three molecules and is capable of accommodating one 
C8 molecule, whichis bound by adsorption without prior enz3,~natic modification. 
The proposed tetramolecular complex has the geometry of a tetrahedron. The 
bound  C8  molecule is  endowed with  multiple  binding  sites  for  C9  and  can 
maximally accommodate six molecules which are attached cooperatively by an 
adsorption process. Since the molecular weight of C8 is 150,000 and that of C9 is 
80,000, the molecular weight of the fully assembled complex, C5blC61C71C8~C9~, 
equals 995,000. Fig. 7 is a photograph of a simple three dimensional model of the 
three assembly stages of the C5-9 complex. 
The proposed molecular concept is predicated essentially on three hypotheses: 
(a)  that  at  the target membrane surface C5,  C6,  and  C7  are bound in  close 
spatial proximity to each other, allowing mutual  physical contact; (b) that the 
C5,6,7  complex constitutes the binding  site  for C8;  and  (c)  that  C8  bears 
multiple binding sites for C9. 
The hypothesis that C5, C6, and C7 are bound to the target cell surface as a 
complex is supported by the following observations. Both  C6 and C7  exhibit 
stereochemical affinity for C5 as was demonstrated by sucrose density gradient 
ultracentrifugation of mixtures of the  three proteins in their native form (3).  2 KOLB,  HAXBY,  ARROYAVE, AND  MI)LLER-EBERItARD  561 
Whereas the complex of the native proteins is readily reversible, C5 and C6 have 
been shown to form a stable complex, C5,6 (6),2 when acted upon by C4,2,3 or 
trypsin.  2 And whereas C5,6 alone is unable to attach itself to a cell (E), binding 
to E occurs in the presence of and together with  C7 (6).* Further, formation of 
ECS, 6,7 by fluid phase C4,2,3 requires the simultaneous presence of C5, C6, 
and C7; an EC5 or EC5,6 intermediate complex was not observed (2). In con- 
tradistinction, C5 may be bound to EAC4,2,3  (4, 5); however, the cytolytic 
activity of the bound molecule decays with a half-life of 2 min at 37°C unless 
C6 and C7 are offered (4). 
The hypothesis that C5, C6, and C7 contribute jointly to the formation of the 
C8 binding site is supported by these observations. The hemolytically effective 
binding of C8 to a membrane requires prior attachment of C5, C6, and C7. Up- 
take of C8 by EAC4-7 is inhibited by pretreatment of the cells with anti-C5, 
anti-C6, or anti-C7, indicating that C5, C6, and C7 are so close to the C8 bind- 
ing site that  antibody molecules directed to any one of the  three molecules 
impose a steric restriction on C8 uptake. In view of the ability of C8 to initiate 
a limited degree of membrane damage in the absence of C9 (20), the possibility 
was considered that C8 binds directly to the membrane, perhaps after enzymatic 
activation by C5,6,7 and subsequent transfer to a membrane receptor. How- 
ever,  if such  a  mechanism  were operative,  enzymatic turnover of  substrate 
(C8)  should produce an amplification of uptake and inactivation of unbound 
molecules as was described for C2  (21), C3  (22),  C4 (23), and C5  (4). These 
latter complement proteins are, in fact, bound only after enzymatic activation 
of their binding sites and transfer to the site of binding, and consequently their 
efficiency of binding is low (5-15 %). In contrast, the efficiency of binding of C8 
may be unusually high, under optimal conditions approaching 70% of input.  7 
There is no amplification of uptake, since the maximal number of C8 molecules 
bound per cell approached but never exceeded the number of bound C5 mole- 
cules (and, by implication, that of bound C6 and C7 molecules). Nor is there 
detectable inactivation of unbound C8 before or after saturation of C8 binding 
sites. Also, uptake of C8 is largely independent of changes in pH, ionic strength, 
and  temperature.  7  Together  these  observations  are  strongly  indicative  of 
uptake of C8 by adsorption to C5,6,7  rather  than  enzymatically catalyzed 
binding to membrane constituents. 
The hypothesis that C9 combines with the C8 portion of the tetramolecular 
complex, C5,6,7,8, is supported by the fact that C9 does not attach to C5, 6,  7 
sites and that the number of C9 molecules bound per cell is governed solely by 
the  number  of  C8  molecules. In  accordance with  this  view is  the  observed 
inhibition of C9 uptake by pretreatment of EAC4-8 with antibody to C8. Also, 
in the case of C9, an enzymatic uptake mechanism may be envisaged (9). That 
1 mole of bound C8 can effect uptake of 6 moles of C9 could be indicative of an 
7 Haxby,  J.  A.,  J.  A.  Manni,  W.  P.  Kolb,  and  H.  J.  Miiller-Eberhard.  Manuscript  in 
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enzymatic reaction. However, at 6 moles of C9/mole of C8, C9 uptake becomes 
,completely independent of the C9 concentration in the reaction mixture. Loss of 
fluid phase C9  activity is satisfactorily accounted for by cellular  C9 uptake, 
and  no  inactivation  of  unbound  C9  is  encountered  after  saturtation  of  all 
~cellular binding sites,  s These observations virtually preclude an enzymatically 
•  catalyzed  binding  reaction.  Direct  evidence  for  stereochemical  affinity  of 
native  C9 for C8 comes from transport experiments in free solution utilizing 
density  gradient  ultracentrifugation. 4 From  the  model  depicted  in  Fig.  7  it 
would appear that spatial considerations impose no restrictions on the associa- 
tion of six C9 molecules with one C8 molecule, even if the latter constitutes a 
•  subunit of a tetrahedron. This applies to two separate triangular arrangements, 
:as depicted,  as to the hexameric arrangements, namely the hexagon,  trigonal 
prism, or octahedron (24), which are not shown. 
The  functional  significance  of multiplicity  for  expression  of  C9  hemolytic 
activity is manifested by the observed sigmoidal dose-response curve (lysis of 
EAC4-8 versus  C9 input)  (Fig. 6). According to this curve, more than  one C9 
molecule per C8 site is required for production of a lyric effect. In addition, the 
also  sigmoldal binding  curve  (C9  uptake  versus  C9  input)  (Fig.  6)  indicates 
cooperative interaction of C9 molecules during the binding process. This means 
that binding of one C9 molecule facilitates uptake of other C9 molecules to the 
same C8 site. Or the affinity of C9 for C8 is low at low C9 concentrations and 
increases with partial saturation of C8. Thus, at partial saturation a  significant 
number of C8 molecules may bear up to six C9 molecules and others none. It 
is not surprising therefore when in a given experiment 63 % lysis [or --ln(1-y) = 
1]  is achieved with  an average molar ratio of bound  C9  to bound  C8  of one 
(Fig. 6). The number of bound C9 molecules required for production of a given 
degree of lysis was found to be inversely related to the number of C8 molecules 
on the cells.  When a respective graphical plot (not shown) was extrapolated to 
very small numbers of C8 molecules per cell,  the number of C9 molecules per 
C8  site,  required  to  cause 63 %  lysis,  approached  three,  s Thus,  although  one 
C8  molecule  can  bind  maximally six  C9  molecules,  the  binding  of  three  C9 
molecules per C8 molecule appears to be sufficient for the production of a  full 
hemolytic effect. In the model shown in Fig. 7, the six C9 molecules are there- 
fore  represented  in  the  form  of  two  triangular  arrangements  bound  sym- 
metrically to  C8.  The  proposed model  may  explain  the  differential  effect of 
anti-C6 or anti-C7 on C9 binding and hemolysis: whereas either antibody should 
sterically  interfere  with  the  binding  of  one  C9  trimer,  it  should  not  affect 
attachment of the other. 
The data are in accord with a possible allosteric effector function of C9. The 
demonstrated ability of a  small molecule such as 2,2~-bipyridine to substitute 
functionally for C9 further emphasizes the probability of an allosteric mecha- 
8  Kolb, W. P., J. A. Haxby, and H. J. Miiller-Eberhard. Manuscript in preparation. KOLB,  HAXBY,  ARROYAVE~ AND  MtILLER-EBERI-IARD  563 
nism. The dose-response curve obtained with bipyridine was also sigmoidal (9). 
The chelating capacity of this compound for bivalent metal ions and the previ- 
ously described inhibition of C9 by ferrous ions (25) strongly implicate a metal 
in the interaction of C8 and C9. Work is underway to examine this hypothesis. 
One of the most intriguing questions, which presently remains unanswered, 
is  how  the  decamolecular  attack  mechanism  affects biological  membranes. 
Several years ago, Fischer (26) speculated that the terminal complement com- 
ponent represents a  phospholipase which by liberating lysolecithin initiates a 
nonenzymatic attack on membrane lipids.  Inoue and Kinsky (27),  working 
with artificial membrane systems containing radiolabeled phospholipids, found 
no evidence for enzymatic degradation of the latter by complement. They sug- 
gested that in analogy to the mode of action of the polyene antibiotics (28), 
complement causes membrane lesions  by hydrophobic interaction with mem- 
brane lipids. 
The characteristic morphological changes of membranes caused by comple- 
ment (29) may well be due to a nonenzymatic, physicochemical effect of one of 
the complement proteins. Recently, these ultrastructural lesions were shown to 
be caused by bound C5 (30), and thus to be distinct from functional membrane 
lesions which permit uncontrolled flux of ions. It appears  likely that,  upon 
removal  of  C5a,  C5b  assumes  transiently the  characteristics  of a  detergent 
protein, displaying a  strongly hydrophobic region with affinity for membrane 
phospholipids. Whereas the resulting rearrangement of membrane constituents 
affects only the outer layer of the membrane,  9 it is conceivable to us that com- 
plete assembly of the C5-9 complex leads to an augmentation of the detergent 
effect of C5 with conversion of an ultrastructural to a functional lesion. The 
manner in which C8, 9 produces a functional lesion, particularly when, as pro- 
posed in this paper, these proteins do not bind directly to the target membrane, 
remains to be explained. 
SUMMARY 
The molecular arrangement of the membrane attack mechanism of comple- 
ment  was  explored.  The  molar  ratios  of  the  components  within  the  C5-9 
assembly on the target cell surface were determined using human complement 
proteins in highly purified and radiolabeled form. With the aid of monospecific 
complement antisera it was possible to probe the spatial relationships between 
the components of the assembly. 
C5 and C6, in the presence of C7, were bound to EAC1-3 in equimolar quanti- 
ties irrespective of the amounts and the relative proportions of C5, C6, and C7 
offered. The  amount of  C8  bound  to EAC1-7  increased with  input  and  at 
saturation  of  all  C8  binding  sites  the  molar  ratio  of  bound  C8/bound  C5 
approached  1.0. Uptake of C9 by EAC1-8 increased with input and at satura- 
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tion of all C9 binding sites  the molar ratio of bound C9/bound C8 became 6.0. 
However, calculations suggest that the binding of three C9 molecules to one C8 
molecule is sufficient to achieve a full hemolytic effect.  Evidence was obtained 
indicating that binding and hemolytic function of C9 depends upon cooperative 
interaction of multiple  C9 molecules. 
Binding  of  C8  to  EAC1-7  and  the  generation  of hemolytic C8  sites  were 
inhibited by antibody to either C5,  C6,  or C7. Uptake of C9 by EAC1-8 and 
the generation of hemolytic C9 sites  were  strongly inhibited  by anti-C8 and 
to  a  lesser  degree  by anti-C5.  Binding  of  C9  (but  not  hemolysis)  was  also 
reduced by antibody to C6 or C7. 
The data are consistent with the concept that the fully assembled membrane 
attack  mechanism  of  complement  consists  of  a  decamolecular  complex:  a 
trimolecular arrangement composed of C5,  C6,  and C7 forms the binding site 
for one C8 molecule which in turn furnishes binding sites for six C9 molecules, 
saturation  of  three  sites  apparently  being  sufficient  for  expression  of  full 
cytolytic activity of the complex. This work made it possible to design a simple 
molecular model. 
We would like to thank Miss Patricia McConahey and Dr. Frank J. Dixon for their in- 
valuable help in introducing radioactive labels into the isolated complement proteins. 
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